Skip to main navigation Skip to search Skip to main content

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial

  • Jordi Giralt
  • , Jose Trigo
  • , Sandra Nuyts
  • , Mahmut Ozsahin
  • , Krzysztof Skladowski
  • , Georges Hatoum
  • , Jean-Francois Daisne
  • , Alejandro César Yunes Ancona
  • , Anthony Cmelak
  • , Ricard Mesía
  • , Alicia Zhang
  • , Kelly S Oliner
  • , Ari VanderWalde
  • Autonomous University of Barcelona
  • Hospital Virgen de la Victoria, Málaga, Spain
  • Katholieke Universiteit Leuven
  • University Hospital of Lausanne
  • Centrum Onkologii Instytut M. Sklodowskiej-Curie, Gliwice, Poland
  • University of Miami
  • Clinique Sainte Elisabeth, Namur, Belgium
  • Unidad de Oncología Servicios de Salud del Estado de Puebla, Puebla, Mexico
  • Vanderbilt University Medical Center
  • Institut Catala d'Oncologia (ICO) – L'Hospitalet, Barcelona, Spain
  • Amgen

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalLancet Oncology
Volume16
Issue number2
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Surgery

Cite this